Skeletal muscle degenerative diseases and strategies for therapeutic muscle repair.
暂无分享,去创建一个
A. Wagers | Mohammadsharif Tabebordbar | Amy J. Wagers | Eric T Wang | Mohammadsharif Tabebordbar | Eric T. Wang
[1] D M Essayan,et al. Cyclic nucleotide phosphodiesterases. , 2001, The Journal of allergy and clinical immunology.
[2] O. Ibraghimov-Beskrovnaya,et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.
[3] B. Thisse,et al. Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo. , 2007, Experimental Cell Research.
[4] A. Delacourte,et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. , 2004, Brain : a journal of neurology.
[5] Krzysztof Sobczak,et al. Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA , 2009, Science.
[6] E. Maestrini,et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy , 1994, Nature Genetics.
[7] R. Trembath,et al. SUN1 Interacts with Nuclear Lamin A and Cytoplasmic Nesprins To Provide a Physical Connection between the Nuclear Lamina and the Cytoskeleton , 2006, Molecular and Cellular Biology.
[8] M. Kyba,et al. Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy , 2009, Experimental Neurology.
[9] S. Wilton,et al. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. , 2003, Human molecular genetics.
[10] N. Romero,et al. Telethonin-deficiency initially presenting as a congenital muscular dystrophy , 2011, Neuromuscular Disorders.
[11] C. Mann,et al. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse , 2003, Nature Medicine.
[12] P. Ward,et al. Complement in ischemia reperfusion injury. , 2003, The American journal of pathology.
[13] J. Kere,et al. Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. , 1999, Human molecular genetics.
[14] M. Ciemerych,et al. Cell cycle regulation during proliferation and differentiation of mammalian muscle precursor cells. , 2011, Results and problems in cell differentiation.
[15] L. Kunkel,et al. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.
[16] A. Wagers,et al. Highly Efficient, Functional Engraftment of Skeletal Muscle Stem Cells in Dystrophic Muscles , 2008, Cell.
[17] Tyson A. Clark,et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy , 2010, Nature Structural &Molecular Biology.
[18] B. Olwin,et al. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. , 2001, Developmental biology.
[19] J. Tidball,et al. Do immune cells promote the pathology of dystrophin-deficient myopathies? , 2001, Neuromuscular Disorders.
[20] M. Dalakas,et al. Review: An update on inflammatory and autoimmune myopathies , 2011, Neuropathology and applied neurobiology.
[21] H. Blau,et al. Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study , 1997, Muscle & nerve.
[22] E. Mercuri,et al. Muscular dystrophies due to defective glycosylation of dystroglycan. , 2007, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[23] G. Cossu,et al. Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues. , 2003, Current opinion in genetics & development.
[24] D. Burkin,et al. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy , 2009, Proceedings of the National Academy of Sciences.
[25] L. Vallier,et al. Induced pluripotent stem cells – alchemist's tale or clinical reality? , 2010, Expert Reviews in Molecular Medicine.
[26] J. Harris,et al. Myotoxic phospholipases A2 and the regeneration of skeletal muscles. , 2003, Toxicon : official journal of the International Society on Toxinology.
[27] J. Ervasti,et al. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.
[28] G. D. Thomas,et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Housman,et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy , 1996, Nature Genetics.
[30] S. Moss,et al. Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.
[31] Jussi Taipale,et al. Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] K. Campbell,et al. Caveolin 3 Is Associated with the Calcium Release Complex and Is Modified via in Vivo Triadin Modification , 2010, Biochemistry.
[33] J. Gilbert,et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. , 2000, Human molecular genetics.
[34] A. Kotulska,et al. Polymyositis, dermatomyositis and inclusion body myositis , 2012 .
[35] T. Südhof,et al. Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy , 2007, PloS one.
[36] T. Partridge. Impending therapies for Duchenne muscular dystrophy. , 2011, Current opinion in neurology.
[37] N. Bourg,et al. Lack of Correlation between Outcomes of Membrane Repair Assay and Correction of Dystrophic Changes in Experimental Therapeutic Strategy in Dysferlinopathy , 2012, PloS one.
[38] C. Bönnemann,et al. Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions , 2010, Current neurology and neuroscience reports.
[39] K. Campbell,et al. Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies , 2002, Nature.
[40] Barbara Gayraud-Morel,et al. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells , 2006, Nature Cell Biology.
[41] J. Beavo,et al. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.
[42] A. Engel,et al. The earliest pathologic alterations in dysferlinopathy , 2001, Neurology.
[43] P. Nido,et al. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation , 2006, Muscle & nerve.
[44] Robert H. Brown,et al. Dysferlin in Membrane Trafficking and Patch Repair , 2007, Traffic.
[45] A. Tu,et al. Isolation of myotoxic component from rattlesnake (Crotalus viridis viridis) venom. Electron microscopic analysis of muscle damage. , 1976, The American journal of pathology.
[46] B. Sacchetti,et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells , 2007, Nature Cell Biology.
[47] Marc S. Williams. Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.
[48] H. Sweeney,et al. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. , 2000, Journal of cell science.
[49] R. Artero,et al. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. , 2006, Differentiation; research in biological diversity.
[50] L. Mei,et al. Biglycan Is an Extracellular MuSK Binding Protein Important for Synapse Stability , 2012, The Journal of Neuroscience.
[51] E Habermann,et al. Bee and wasp venoms. , 1972, Science.
[52] A. Sica,et al. Macrophage polarization comes of age. , 2005, Immunity.
[53] G. Bassez,et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. , 2007, Molecular biology of the cell.
[54] Guey-Shin Wang,et al. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. , 2007, Molecular cell.
[55] K. Davies,et al. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. , 1999, Human gene therapy.
[56] A. Wernig,et al. Expression of Cd34 and Myf5 Defines the Majority of Quiescent Adult Skeletal Muscle Satellite Cells , 2000, The Journal of cell biology.
[57] J. García-Verdugo,et al. Absence of Dysferlin Alters Myogenin Expression and Delays Human Muscle Differentiation “in Vitro”* , 2006, Journal of Biological Chemistry.
[58] J. Beckmann,et al. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IκBα/NF-κB survival pathway in skeletal muscle , 2001, Journal of Molecular Medicine.
[59] K. Davies,et al. Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse , 2011, PloS one.
[60] Jeffrey M. Statland,et al. Facioscapulohumeral muscular dystrophy , 2008, Neurotherapeutics.
[61] D. Housman,et al. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues , 1995, The Journal of cell biology.
[62] Eric T. Wang,et al. Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching. , 2012, Journal of the American Chemical Society.
[63] Marinos C. Dalakas. Immunopathogenesis of inflammatory myopathies , 1995, Annals of neurology.
[64] A. Wagers,et al. Stem cells for skeletal muscle repair , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.
[65] J. Ervasti,et al. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice. , 2011, Journal of applied physiology.
[66] I. Kiss,et al. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. , 1997, Development.
[67] Gene table of monogenic neuromuscular disorders (nuclear genome only) , 2009, Neuromuscular Disorders.
[68] B. Byrne,et al. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.
[69] C. Greenberg,et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). , 1999, Human molecular genetics.
[70] N. Bresolin,et al. Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts , 2003, Science.
[71] T. Cooper,et al. RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1 , 2012, Proceedings of the National Academy of Sciences.
[72] M. Sinha,et al. Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. , 2011, Cold Spring Harbor symposia on quantitative biology.
[73] K. Campbell,et al. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb–girdle muscular dystrophies , 2000, Annals of neurology.
[74] R. Finkel. Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124) , 2010, Journal of child neurology.
[75] G. Piluso,et al. Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches. , 2011, Current opinion in neurology.
[76] Abraham P. Fong,et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. , 2012, Developmental cell.
[77] R. J. White,et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.
[78] T. Khurana,et al. Myostatin propeptide‐mediated amelioration of dystrophic pathophysiology , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[79] F. Baas,et al. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. , 2010, American journal of human genetics.
[80] T. Cooper,et al. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. , 2005, Human molecular genetics.
[81] K. Wilson,et al. BAF: roles in chromatin, nuclear structure and retrovirus integration. , 2004, Trends in cell biology.
[82] D. Bredt,et al. Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.
[83] M. Dalakas. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. , 2010, Current opinion in pharmacology.
[84] Lucy M. Brown,et al. Some observations on variations in filament overlap in tetanized muscle fibres and fibres stretched during a tetanus, detected in the electron microscope after rapid fixation , 1991, Journal of Muscle Research & Cell Motility.
[85] R. Stewart,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[86] G. van Ommen,et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule , 2006, Muscle & nerve.
[87] C. Hsiao,et al. Structural Basis of Membrane-induced Cardiotoxin A3 Oligomerization* , 2003, Journal of Biological Chemistry.
[88] C. Maltin,et al. The Neurotoxicity of the Venom Phospholipases A2, Notexin and Taipoxin , 2000, Experimental Neurology.
[89] T. Cooper,et al. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.
[90] W. Groh. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 , 2011, Neurology.
[91] T. Rando,et al. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. , 2002, Developmental cell.
[92] M. Cullen,et al. Muscle necrosis caused by snake venoms and toxins. , 1990, Electron microscopy reviews.
[93] K. Bushby,et al. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. , 2006, Human molecular genetics.
[94] S. Bione,et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. , 2000, American journal of human genetics.
[95] D. Housman,et al. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[96] K. Mathews,et al. Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.
[97] Michael A. Rudnicki,et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis , 2010, Nature Cell Biology.
[98] L. Verdijk,et al. The impact of sarcopenia and exercise training on skeletal muscle satellite cells , 2009, Ageing Research Reviews.
[99] D. Watt,et al. Muscle stem cells , 2002, The Journal of pathology.
[100] P. Mcneil,et al. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. , 1992, The American journal of pathology.
[101] Steven S Vogel,et al. The endomembrane requirement for cell surface repair , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[102] R. Mulligan,et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.
[103] Se-Jin Lee,et al. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.
[104] A. Nakamura,et al. Clinical Characteristics of Aged Becker Muscular Dystrophy Patients with Onset after 30 Years , 1999, European Neurology.
[105] S. Antonini,et al. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. , 2011, Nature communications.
[106] H. Sweeney,et al. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. , 1999, The Journal of clinical investigation.
[107] W. Hauswirth,et al. A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.
[108] Gayle M. Smythe,et al. Notch-Mediated Restoration of Regenerative Potential to Aged Muscle , 2003, Science.
[109] K. Patel,et al. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity , 2009, Proceedings of the National Academy of Sciences.
[110] G. Pinkus,et al. Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis , 2005 .
[111] L. Kunkel,et al. Drug screening in a zebrafish model of Duchenne muscular dystrophy , 2011, Proceedings of the National Academy of Sciences.
[112] R Hohlfeld,et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. , 1996, The Journal of clinical investigation.
[113] J. Weber,et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4 , 1990, The Lancet.
[114] J. Sanes. The Basement Membrane/Basal Lamina of Skeletal Muscle* , 2003, The Journal of Biological Chemistry.
[115] M. Rudnicki,et al. Pax7 Is Required for the Specification of Myogenic Satellite Cells , 2000, Cell.
[116] W. Engel,et al. Inclusion Body Myositis: A Degenerative Muscle Disease Associated with Intra‐Muscle Fiber Multi‐Protein Aggregates, Proteasome Inhibition, Endoplasmic Reticulum Stress and Decreased Lysosomal Degradation , 2009, Brain pathology.
[117] K. Miyake,et al. Calpain Is Required for the Rapid, Calcium-dependent Repair of Wounded Plasma Membrane* , 2007, Journal of Biological Chemistry.
[118] J. Vencovský,et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen , 2006 .
[119] Gregory Q. Wallace,et al. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. , 2009, Annual review of physiology.
[120] M. Blasco,et al. A Subpopulation of Adult Skeletal Muscle Stem Cells Retains All Template DNA Strands after Cell Division , 2012, Cell.
[121] J. Tidball,et al. Inflammatory cell response to acute muscle injury. , 1995, Medicine and science in sports and exercise.
[122] Johan T den Dunnen,et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. , 2008, Human molecular genetics.
[123] M. Swanson,et al. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[124] Tetsuo Ashizawa,et al. Somatic instability of CTG repeat in myotonic dystrophy , 1993, Neurology.
[125] G. Bulkley,et al. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. , 1987, Surgery.
[126] N. Bourg,et al. Calpain 3 Is Activated through Autolysis within the Active Site and Lyses Sarcomeric and Sarcolemmal Components , 2003, Molecular and Cellular Biology.
[127] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell‐mediated cytotoxicity and muscle fiber necrosis , 1988, Annals of neurology.
[128] Kristy L. Townsend,et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat , 2010, Proceedings of the National Academy of Sciences.
[129] A. Rabinowitz,et al. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology , 2006, Nature Medicine.
[130] P. Gopalakrishnakone,et al. Morphological changes induced by crotoxin in murine nerve and neuromuscular junction. , 1984, Toxicon : official journal of the International Society on Toxinology.
[131] M. Kyba,et al. Functional Myogenic Engraftment from Mouse iPS Cells , 2011, Stem Cell Reviews and Reports.
[132] G. Valle,et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin , 2000, Nature Genetics.
[133] C. Wijmenga,et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy , 1992, Nature genetics.
[134] H. Worman,et al. How do mutations in lamins A and C cause disease? , 2004, The Journal of clinical investigation.
[135] C. Keller,et al. Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis , 2007, Science.
[136] T. Rando,et al. High Incidence of Non-Random Template Strand Segregation and Asymmetric Fate Determination In Dividing Stem Cells and their Progeny , 2007, PLoS biology.
[137] G. Lynch,et al. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. , 2002, The American journal of pathology.
[138] S. Delp,et al. Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.
[139] J. Ervasti,et al. Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.
[140] J. Tidball. Inflammatory processes in muscle injury and repair. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[141] B. Wieringa,et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy , 2009, Proceedings of the National Academy of Sciences.
[142] Jeanne Shen,et al. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. , 2008, Cell stem cell.
[143] Q. Gong,et al. Similarities and differences in mechanisms of cardiotoxins, melittin and other myotoxins. , 1996, Toxicon : official journal of the International Society on Toxinology.
[144] E. McNally,et al. Muscle diseases: the muscular dystrophies. , 2007, Annual review of pathology.
[145] G. Bi,et al. Calcium-regulated exocytosis is required for cell membrane resealing , 1995, The Journal of cell biology.
[146] S. Agrawal,et al. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides , 1999, Neuromuscular Disorders.
[147] A. Baranger,et al. A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding , 2009, Proceedings of the National Academy of Sciences.
[148] J. Lueck,et al. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. , 2007, The Journal of clinical investigation.
[149] Daniel G. Miller,et al. A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.
[150] G. Zimmerman,et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. , 1988, The Journal of clinical investigation.
[151] E. Boerwinkle,et al. Anticipation in myotonic dystrophy , 1992, Neurology.
[152] M. Nakamori,et al. Pentamidine reverses the splicing defects associated with myotonic dystrophy , 2009, Proceedings of the National Academy of Sciences.
[153] C. Ottenheijm,et al. Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy. , 2010, The Journal of clinical investigation.
[154] Nicolas A. Dumont,et al. Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[155] L. Lescaudron,et al. Macrophages enhance muscle satellite cell proliferation and delay their differentiation , 1999, Muscle & nerve.
[156] A. Engel,et al. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. , 1989, Human pathology.
[157] F. Zara,et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy , 1998, Nature Genetics.
[158] J. Fallon,et al. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice , 2010, Proceedings of the National Academy of Sciences.
[159] S. Manilal,et al. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. , 1996, Human molecular genetics.
[160] A. Mauro. SATELLITE CELL OF SKELETAL MUSCLE FIBERS , 1961, The Journal of biophysical and biochemical cytology.
[161] B. Thiers. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .
[162] A. Laquérriere,et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy , 2011, Nature Medicine.
[163] J. Léger,et al. Direct visualization of the dystrophin network on skeletal muscle fiber membrane , 1992, The Journal of cell biology.
[164] F. Baas,et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). , 2000, Human molecular genetics.
[165] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.
[166] L. Kunkel,et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. , 2002, The Journal of clinical investigation.
[167] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.
[168] J. Beckmann,et al. Calpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans , 2003 .
[169] D. Sandonà,et al. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects , 2009, Expert Reviews in Molecular Medicine.
[170] M. Kyba,et al. Assessment of the Myogenic Stem Cell Compartment Following Transplantation of Pax3/Pax7‐Induced Embryonic Stem Cell‐Derived Progenitors , 2011, Stem cells.
[171] A. Rabinowitz,et al. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[172] L. Duchen,et al. Changes in motor end-plates resulting from muscle fibre necrosis and regeneration. A light and electron microscopic study of the effects of the depolarizing fraction (cardiotoxin) of Dendroaspis jamesoni venom. , 1974, Journal of the neurological sciences.
[173] I. Conboy,et al. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells , 2008, Nature.
[174] R. Ahima,et al. Functional improvement of dystrophic muscle by myostatin blockade , 2002, Nature.
[175] J. Mendell,et al. Microvascular deposition of complement membrane attack complex in dermatomyositis. , 1986, The New England journal of medicine.
[176] D. Morgan,et al. Early events in stretch-induced muscle damage. , 1999, Journal of applied physiology.
[177] L. Lescaudron,et al. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant , 1999, Neuromuscular Disorders.
[178] I. Graham,et al. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study , 2009, The Lancet Neurology.
[179] D. Wells,et al. Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophy , 2002, Expert Reviews in Molecular Medicine.
[180] D. Escolar,et al. Pharmacologic and genetic therapy for childhood muscular dystrophies , 2001, Current neurology and neuroscience reports.
[181] J. Powell,et al. Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo. , 1997, Toxicon : official journal of the International Society on Toxinology.
[182] Giulio Cossu,et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs , 2006, Nature.
[183] F. Muntoni,et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.
[184] A. Cumano,et al. An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells. , 2010, Stem cell research.
[185] R. Tawil,et al. Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.
[186] I. Weissman,et al. Isolation of Adult Mouse Myogenic Progenitors Functional Heterogeneity of Cells within and Engrafting Skeletal Muscle , 2004, Cell.
[187] G. Lynch,et al. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice , 2001, Neuromuscular Disorders.
[188] A. Manzur,et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. , 2004, The Cochrane database of systematic reviews.
[189] N. Goemans,et al. T.O.4 A phase I/IIa study on antisense compound PRO051 in patients with Duchenne muscular dystrophy , 2009, Neuromuscular Disorders.
[190] C. Gregorio,et al. Muscle assembly: a titanic achievement? , 1999, Current opinion in cell biology.
[191] J. Sanger,et al. The Dynamic Z Bands of Striated Muscle Cells , 2008, Science Signaling.
[192] A. Belcastro,et al. Exercise-induced muscle injury: A calpain hypothesis , 1998, Molecular and Cellular Biochemistry.
[193] Pieter J. de Jong,et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.
[194] R. Moxley,et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. , 2012, Human molecular genetics.
[195] Juliet A. Ellis,et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. , 2007, Human molecular genetics.
[196] U. Carraro,et al. ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. , 1997, Biochemical and biophysical research communications.
[197] C. Kerrigan,et al. Ischemia reperfusion injury: A review , 1993, Microsurgery.
[198] L. Kunkel,et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. , 1996, Human molecular genetics.
[199] S. Naylor,et al. Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.
[200] N. Kasuga,et al. Eccentric exercise‐induced morphological changes in the membrane systems involved in excitation—contraction coupling in rat skeletal muscle , 2001, The Journal of physiology.
[201] Renzhi Han,et al. Dysferlin and muscle membrane repair. , 2007, Current opinion in cell biology.
[202] I. Nonaka,et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. , 2001, Human molecular genetics.
[203] B. Mittal,et al. Point mutation and polymorphism in Duchenne/Becker Muscular Dystrophy (D/BMD) patients , 2001, Experimental & Molecular Medicine.
[204] Seumas McCroskery,et al. Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.
[205] M. Oshimura,et al. Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[206] P. Ray,et al. A cDNA clone from the Duchenne/Becker muscular dystrophy gene , 1987, Nature.
[207] J G Cannon,et al. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. , 1993, The American journal of physiology.
[208] K. Campbell,et al. Association of dystrophin and an integral membrane glycoprotein , 1989, Nature.
[209] J. Ervasti,et al. Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice , 2009, PLoS medicine.
[210] E. Kudryashova,et al. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. , 2005, Journal of molecular biology.
[211] Benjamin L Miller,et al. Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). , 2008, Journal of the American Chemical Society.
[212] T. Cooper,et al. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy , 2001, Nature Genetics.
[213] L Politano,et al. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies , 2001, Neuromuscular Disorders.
[214] Paul T Martin,et al. Congenital muscular dystrophies involving the O-mannose pathway. , 2007, Current molecular medicine.
[215] E. Clementi,et al. Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion , 2006, The Journal of cell biology.
[216] E. Feldman,et al. Insulin-like Growth Factor-I in Muscle Metabolism and Myotherapies , 2001, Neurobiology of Disease.
[217] Isabelle Richard,et al. Calpain 3: a key regulator of the sarcomere? , 2006, The FEBS journal.
[218] J. Tidball,et al. The role of free radicals in the pathophysiology of muscular dystrophy. , 2007, Journal of applied physiology.
[219] K. Jellinger. Myotonic Dystrophy: Present Management, Future Therapy , 2004 .
[220] K. Tsuchida,et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle , 2010, Nature Cell Biology.
[221] S. Yamanaka,et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[222] D. Cocchi,et al. Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function , 1999, Neuromuscular Disorders.
[223] R. Rojas-García,et al. Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients , 2001, Neurology.
[224] K. Davies,et al. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. , 2002, Human molecular genetics.
[225] J. Tremblay,et al. Myoblast Transplantation : a Brief Review of the Problems and of Some Solutions , 2007 .
[226] I. Weissman,et al. Determinants of Skeletal Muscle Contributions from Circulating Cells, Bone Marrow Cells, and Hematopoietic Stem Cells , 2004, Stem cells.
[227] J. Chamberlain,et al. Emerging strategies for cell and gene therapy of the muscular dystrophies , 2009, Expert Reviews in Molecular Medicine.
[228] Jessica L. Childs-Disney,et al. Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. , 2009, Journal of the American Chemical Society.
[229] T. Cooper,et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.
[230] F. Muntoni,et al. Oxidative stress in SEPN1‐related myopathy: From pathophysiology to treatment , 2009, Annals of neurology.
[231] H. Takeshima,et al. Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair , 2009, Communicative & integrative biology.
[232] H. Lodish,et al. Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*) , 1996, The Journal of Biological Chemistry.
[233] T. Rando,et al. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. , 2005, Trends in cell biology.
[234] K. Davies,et al. Primary structure of dystrophin-related protein , 1992, Nature.
[235] G. Butler-Browne,et al. In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[236] T. Ashizawa,et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.
[237] Michael Kyba,et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells , 2008, Nature Medicine.
[238] Chien-Chang Chen,et al. Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.
[239] Michel Georges,et al. A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle , 1997, Nature Genetics.
[240] C. Catani,et al. Macrophages regulate proliferation and differentiation of satellite cells. , 1994, Biochemical and biophysical research communications.
[241] T. Partridge,et al. Muscle satellite cells adopt divergent fates , 2004, The Journal of cell biology.
[242] Meenal Patel,et al. PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.
[243] J. Barrett,et al. Resealing of transected myelinated mammalian axons in vivo: evidence for involvement of calpain , 1999, Neuroscience.
[244] M. Grounds,et al. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice , 1987, Cell and Tissue Research.
[245] B. Hyman,et al. Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing* , 2003, Journal of Biological Chemistry.
[246] M. Young,et al. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. , 2004, Developmental biology.
[247] K. Bushby,et al. Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display , 2005, European Journal of Human Genetics.
[248] I. Weissman,et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.
[249] A. Bootsma,et al. Satellite cell activation after muscle damage in young and adult rats , 1995, The Anatomical record.
[250] Helen M. Blau,et al. Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury , 2002, Cell.
[251] E. Bertini,et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy , 2008, Annals of neurology.
[252] C. Amemiya,et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.
[253] G. Lynch,et al. Administration of insulin‐like growth factor‐I improves fatigue resistance of skeletal muscles from dystrophic mdx mice , 2004, Muscle & nerve.
[254] H. Worman,et al. Emery-Dreifuss muscular dystrophy , 2007, Current neurology and neuroscience reports.
[255] M. Mcdermott,et al. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 , 2010, Neurology.
[256] J. Gutiérrez,et al. Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. , 2003, Toxicon : official journal of the International Society on Toxinology.
[257] Johan T den Dunnen,et al. Local dystrophin restoration with antisense oligonucleotide PRO051. , 2007, The New England journal of medicine.
[258] D. Bedwell,et al. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. , 2000, RNA.
[259] M. Swanson,et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. , 1996, Nucleic acids research.
[260] P. Mcneil,et al. Requirement for Annexin A1 in Plasma Membrane Repair* , 2006, Journal of Biological Chemistry.
[261] J. Siliciano,et al. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.